Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MPP7 divergent transcript (MPP7-DT) refers to a putative long non-coding RNA (lncRNA) transcribed in a divergent orientation from the promoter region of the MPP7 gene. Divergent transcription is a common phenomenon in mammalian genomes, producing non-coding RNAs that arise upstream and antisense to coding genes[2][6]. While divergent transcripts can sometimes play a role in transcriptional regulation, particularly for developmental regulators, there is no current evidence that MPP7-DT itself is a defined molecular entity, functional gene product, or therapeutic target. MPP7-DT appears as a database placeholder for such an antisense or upstream transcript, and not as a characterized receptor, enzyme, or disease target[3]. Key reasons why this is not a standard target and is marked as incorrect: - There is no evidence that "MPP7 divergent transcript" has been characterized as a gene product with function, nor is it a protein, receptor, or established target class. - Divergent transcripts are widespread, and many have unknown function; their naming follows systematic annotation rather than functional characterization[2][6]. - No aliases, drugs, or disease/biomarker information is associated with MPP7-DT. In summary, "MPP7 divergent transcript" is a bioinformatic annotation for a possible divergent long non-coding RNA from the MPP7 gene locus, not a validated molecule or therapeutic target[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MPP7 divergent transcript (MPP7-DT).